Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683442
What this trial is testing
The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal Threshold
Who this might be right for
OSA - Obstructive Sleep Apnea
Chulalongkorn University 36